← Back to Search

Behavioural Intervention

e-hookah vaping with nicotine for Endothelial Dysfunction

N/A
Waitlist Available
Led By Mary Rezk-Hanna, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes pre- and post- the 30-minute smoking or vaping exposure sessions
Awards & highlights

Study Summary

This trial will investigate the effects of e-hookah bowl inhalation on endothelial function and vascular biomarkers in young healthy hookah smokers.

Eligible Conditions
  • Endothelial Dysfunction
  • Smoking

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes pre- and post- the 30-minute smoking or vaping exposure sessions
This trial's timeline: 3 weeks for screening, Varies for treatment, and changes pre- and post- the 30-minute smoking or vaping exposure sessions for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acetylcholine-stimulated nitric oxide production
Basal reactive oxygen species bioactivity
Carbon monoxide levels
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: e-hookah vaping without nicotineExperimental Treatment2 Interventions
Participants were invited to vape a 30-minute electronic hookah without nicotine vaping session, followed by a 30-minute electronic hookah with nicotine vaping session. To mitigate the impact of carryover effects, the two sessions were separated by a minimum of 7-days.
Group II: e-hookah vaping with nicotineExperimental Treatment2 Interventions
Participants were invited to vape a 30-minute electronic hookah with nicotine vaping session, followed by a 30-minute electronic hookah without nicotine vaping session. To mitigate the impact of carryover effects, the two sessions were separated by a minimum of 7-days.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,276,818 Total Patients Enrolled
5 Trials studying Endothelial Dysfunction
331 Patients Enrolled for Endothelial Dysfunction
Tobacco Related Disease Research ProgramOTHER
25 Previous Clinical Trials
20,585 Total Patients Enrolled
Mary Rezk-Hanna, PhDPrincipal Investigator - University of California, Los Angeles
University of California, Los Angeles

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical experiment accept participants aged 25 or older?

"According to the regulation of this medical experiment, only those between 21 and 39 years old are qualified. Additionally, 8 other studies focus on participants under 18 while 87 trials seek patients above 65."

Answered by AI

Are there any specific requirements that must be met in order to join this medical trial?

"This clinical trial has limited its participants to those between 21 and 39 years old who are current smokers. A total of 18 individuals will be accepted for the study."

Answered by AI

What is the size of this clinical research project?

"That is correct. The clinicaltrials.gov database indicates that recruitment for this trial, initially posted on November 1st 2019, is still underway. 18 participants are needed across a single site in total."

Answered by AI

Is recruitment for this experiment open at present?

"According to clinicaltrials.gov, this trial is currently recruiting patients. It was first announced on November 1st 2019 and the most recent update was published on September 1st 2022."

Answered by AI
~6 spots leftby Apr 2025